Management Team of Adamed Pharma S.A.

He is a graduate of the Warsaw School of Economics (Faculty of Foreign Trade) and Taras Shevchenko National University of Kyiv. He began his professional career in the financial sector, where he spent over a decade in the capital markets. Between 1997 and 2008, he worked at Centralny Dom Maklerski Pekao S.A., progressing through all career stages from

Read more

analyst to Director of the Capital Markets Department. He subsequently continued his career at UniCredit CAIB, where, as Managing Director, he was responsible for the investment banking division, executing complex transactions for leading market players.

He has been associated with the Adamed Group since 2012. As a Member of the Management Board and Managing Director, he co-develops and implements the company’s long-term growth strategy, overseeing key investment projects and supporting financial and strategic decision-making across the organisation. He combines deep financial expertise with a strong strategic perspective, with a particular focus on international expansion, business diversification, and strengthening Adamed’s position in global pharmaceutical markets.

In parallel, he is actively involved in the development of technology- and innovation-driven ventures, supporting early-stage projects, their scaling, and commercialisation. He also serves on the supervisory boards of technology companies in Poland and the United States.

He is actively engaged in advancing innovation in healthcare and fostering collaboration between the public and private sectors, supporting initiatives that strengthen the innovation ecosystem and facilitate knowledge transfer.

Tomasz Krzak has been with Adamed Pharma since 2014 and has served as a Member of the Management Board since January 2017. He is responsible for key strategic areas such as human capital development, organizational culture, the legal department, internal audit, corporate communications, cybersecurity, and administration.

Read more

He has over 20 years of experience in human resources management, organizational transformation, and employee relations – including negotiations with trade unions. He began his professional career at Śnieżka S.A. Paint and Varnish Factory, where he was involved in the company’s IPO on the Warsaw Stock Exchange. He then gained experience in international organizations – Fresenius Kabi and L'Oréal – where he held executive roles, overseeing markets in Poland, Eastern Europe, and the Baltic States.

He holds degrees in Law from the University of Silesia and in Journalism from the Jagiellonian University. He completed postgraduate studies in Human Resource Management at the Warsaw School of Economics and participated in prestigious executive programs, including the Senior Executive Programme at London Business School and the People, Culture & Performance program in Silicon Valley at Stanford Graduate School of Business.

He is passionate about creating an engaging work environment based on trust, values, and shared responsibility. He believes that the strength of any organization lies in the potential and commitment of its people.

Graduate of the Wroclaw University of Economics and Business, where he was awarded his PhD in Economics in 2002. Holder of a scholarship in Project Planning and Analysis at the University of Bradford, granted by the UK Government (2005). In 2000–2009, a university lecturer at the Wroclaw University of Economics and Business, as well

Read more

as WSB University in Wrocław, among others.

An experienced manager, he has worked in the pharmaceutical sector since 2003. In 2006–2008, he held the role of Managing Director of the Polish-German Research Association (EEIG). Since 2017, he has been a Member of the Board of Directors at Davipharm. In 2018–2020, he held the role of Member of the Economic Council of the Lodz Province.

Bartłomiej Rodawski has authored more than a dozen articles on supply chain management in the pharmaceutical sector, as well as a report called: “Supply Chain Management in the Pharmaceutical Sector in Poland in 2008” which was published by PMR Institute. Throughout his professional career, he has run analytical, training and implementation projects in the pharmaceutical, FMCG, logistics and service sectors.

He has worked at Adamed since 2009. Since 2013, he has been a Member of the Management Board and Chief Operating Officer. He is in charge of the co-development and implementation of the strategy for the development of broadly understood supply chain, including production, quality, logistics, and technology.

A graduate in Biotechnology from the Faculty of Chemistry at Gdańsk University of Technology. Holds an Executive MBA from Kozminski University in Warsaw.
She also completed postgraduate studies in Business Management and Project Management at WSB University in Gdańsk.

Read more

She has been working in the R&D field for over 20 years. Between 2002 and 2014, she worked at ZF Polpharma S.A., including roles as R&D Project Team Coordinator, Project Manager in the Regulatory Affairs Department, and Head of Pharmaceutical Analysis Development. During this time, she led both national and global initiatives, such as harmonizing registration documentation for WZF Polfa Warsaw products and implementing European R&D standards in Kazakhstan’s largest local drug factory.

She has been with Adamed Pharma since 2015. Initially, she served as Director of the Generic Business Division. Since 2018, she has held the position of Director of Research and Development. She is jointly responsible for shaping and implementing R&D strategy, including expanding the company’s product portfolio by managing the full scope of R&D projects — from idea to marketing authorization — across over 90 global markets. Her responsibilities include overseeing research and development laboratories (analytical, organic synthesis, preformulation, formulation, inhalation drug development), R&D pilot-scale production, clinical research teams, and the Regulatory Affairs & Pharmacovigilance Department.

Since April 2022, she has been a Member of the Management Board at Adamed Pharma S.A.

Completed Management Education at London Business School. Graduate of ACCA studies and MBA program at the Warsaw University of Technology run in cooperation with London Business School, HEC Paris, and the Norwegian School of Economics.
Involved with Adamed Pharma since 2023. Prior to joining the company, he served as the CFO for

Read more

the CFO for business operations at Polpharma Group, with roles as a member of the company’s Management Board and Supervisory Board. He was responsible for the creation and development of the entire function of finance for business operations at Polpharma. During that time, he also held the positions of Vice-President for Finance at Polfa Lublin, Member of the Supervisory Board of Herbapol Lublin, and the Polpharma Scientific Foundation. In addition, throughout his professional career, he worked as an advisor at Belvedere Group and SenseMedConcept, with responsibility for the implementation of systems and establishment of reporting standards and managerial dashboards.

At Adamed Pharma, he is in charge of the Financial Area, with duties including the formulation and implementation of a financial strategy for the entire organization. In collaboration with the Management Team and the Supervisory Board, he develops and implements Adamed’s growth strategy for the Polish and foreign markets.

Dr Karolina Czekaj is a graduate of the Cracow University of Economics and holds a PhD in economics from the Wrocław University of Economics. She completed the prestigious Transition to General Manager program at INSEAD. She began her professional career in capital market financial institutions. She has been associated with Adamed

Read more

Pharma since 2013.

For several years, she was responsible for financial liquidity, working capital management policy, and securing external funding for development. She is currently responsible for corporate-level finance, taxation, capital investments, strategic projects, and ownership supervision. She is also involved in Adamed Technology projects, focused primarily on supporting start-ups in the fields of medicine and healthcare. She serves as Chairwoman of the Supervisory Board of drEryk S.A.